1. Home
  2. CHRS vs OGI Comparison

CHRS vs OGI Comparison

Compare CHRS & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

HOLD

Current Price

$1.82

Market Cap

186.0M

Sector

Health Care

ML Signal

HOLD

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

HOLD

Current Price

$1.48

Market Cap

174.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHRS
OGI
Founded
2010
2013
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.0M
174.3M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
CHRS
OGI
Price
$1.82
$1.48
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.51
N/A
AVG Volume (30 Days)
1.7M
773.8K
Earning Date
04-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
109.88
N/A
EPS
1.77
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.10
Revenue Next Year
$79.63
$13.92
P/E Ratio
$0.99
$13.91
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.85
52 Week High
$2.62
$2.24

Technical Indicators

Market Signals
Indicator
CHRS
OGI
Relative Strength Index (RSI) 52.42 50.82
Support Level $1.55 $1.47
Resistance Level $1.89 $1.51
Average True Range (ATR) 0.09 0.07
MACD 0.00 0.02
Stochastic Oscillator 90.57 80.00

Price Performance

Historical Comparison
CHRS
OGI

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Share on Social Networks: